• Home
  • About Us
    • Leadership Team
    • Scientific Advisory Board
    • Crystal Panel
    • Webinar Series
    • Careers
  • Services
    • Solid Form Screening and Selection
    • Crystallization Development
    • Preclinical and Tox Formulation Development
    • Chiral Separation by Crystallization
    • Single Crystal Growth and Structure Determination
    • Micro ED
    • In-Silico Modeling
    • Solid-State NMR
    • Solid State Characterization (FAST)
    • Crystal Formulation Services
  • Resources
    • Company Overview
    • Whitepapers
    • Presentations
  • Contact Us
  • 中文

Whitepapers




Click Whitepaper Title to view in 

a new window or download.


微信图片_20220119143711.png


Amorphous Solid Dispersions


API Crystallization


Co-crystals


Early Development


Preclinical Formulation Development


Salts


Solid Forms




  • USA Site (Cranbury, NJ)
  • Cell: 609-529-4135 (USA)
  • Tel: 609-604-8303 (USA)
  • Email: Mailisi_Heshuote@crystalpharmatech-global.com
  • Address:
  • 3000 Eastpark Blvd. Suite 500B, Cranbury New Jersey 08512
  • China Site (Suzhou, Jiangsu)
  • Cell: +86 189-3459-7531 (CN)
  • Tel: +86 512-69561921 ext. 807 (CN)
  • Email: collaboration@crystalpharmatech.com
  • Address:
  • Suite B4-101, 218 Xinghu Streets, Suzhou Industrial Park, Suzhou, China, 215123
Request a Quote


苏ICP备11027398号 © 2021 苏州晶云药物科技股份有限公司